Survival in patients with recurrent squa
✍
Mario Airoldi; Antonella De Stefani; Sara Marchionatti; Fulvia Pedani; Pietro Ga
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 94 KB
👁 2 views
## Abstract ## Background We have shown that rIL‐2 administration in recurrent head and neck cancers induces a tumor‐specific T‐lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5‐fluorouracil. Long‐term results